Summary information

Study title

Non-invasive Prenatal Testing Study: Comparison England, France, Germany, 2021-2022

Creator

Horn, R, University of Oxford

Study number / PID

855970 (UKDA)

10.5255/UKDA-SN-855970 (DOI)

Data access

Restricted

Series

Not available

Abstract

This project proposed a new approach to explore ethical issues arising from the clinical implementation of genomics in antenatal care in the twenty first century. Situated at the interface between sociology, bioethics and law/social policy this research seeks to gain in-depth understanding of the situations in which these questions emerge and are experienced by the key-stakeholders (health professionals, patients, scientists, policy-makers), and provide insight into the underlying value systems which promote them. This comparative investigation takes non-invasive prenatal testing (NIPT) in England, France and Germany as a case study. NIPT is a rapidly developing genomic technology that is constantly widening its scope and opening up new possibilities in reproductive medicine. These data are part of a wider comparative study combining a literature review and an empirical research (semi-structured interviews with different stakeholders, including pregnant women/couples and health professionals) to explore the ethical issues arising from prenatal genetics and genomics in England, France and Germany.This project proposes a new approach to explore ethical issues arising from the clinical implementation of genomics in antenatal care in the twenty first century. Situated at the interface between sociology, bioethics and law/social policy this research seeks to gain in-depth understanding of the situations in which these questions emerge and are experienced by the key-stakeholders (health professionals, patients, scientists, policy-makers), and provide insight into the underlying value systems which promote them. This comparative investigation takes non-invasive prenatal testing (NIPT) in England, France and Germany as a case study. NIPT is a rapidly developing genomic technology that is constantly widening its scope and opening up new possibilities in reproductive medicine. Since 2011, NIPT, which uses cell-free foetal DNA in the maternal blood, has been commercially...
Read more

Topics

Methodology

Data collection period

01/09/2021 - 31/12/2022

Country

United Kingdom, France, Germany (October 1990-)

Time dimension

Not available

Analysis unit

Individual

Universe

Not available

Sampling procedure

Not available

Kind of data

Text

Data collection mode

The interviews were semi-structured and we used a thematic guide to collect the experience of pregnant women/couples, health professionals and scientists in relation to the publicly funded offer of standard NIPT in England, France and Germany.

Funding information

Grant number

ES/T00908X/1

Access

Publisher

UK Data Service

Publication year

2022

Terms of data access

The Data Collection is available for download to users registered with the UK Data Service.

Related publications

Not available